$INT has been for a while delisted and I have it in my Traderepublic account.
Can anyone let me know what can I do to be able to confirm the loss? I have used the chat support but still no answer.
I am based in Spain btw. Thank you for your help
Puestos
37$INT has been for a while delisted and I have it in my Traderepublic account.
Can anyone let me know what can I do to be able to confirm the loss? I have used the chat support but still no answer.
I am based in Spain btw. Thank you for your help
Press release from Intellego $INT from 04.03.2026......
The Disciplinary Committee of Nasdaq Stockholm has decided to delist the shares of Intellego Technologies AB (publ) from the Nasdaq First North Growth Market
from March 4, 2026
Intellego Technologies AB (publ) (the "company" or "Intellego") has today, March 4, 2026, received a decision from the Disciplinary Committee of Nasdaq Stockholm that the Company's shares must be removed from the Nasdaq First North Growth Market trading platform due to serious violations of the Nasdaq First North Growth Market rules for equity issuers and the EU Market Abuse Regulation.
"Given the company's historic actions, the decision was to be expected. Since the extraordinary general meeting in February, the new board has tried to arrange meetings with Nasdaq to discuss a way forward, but these have been rejected", says Fredrik Olsson, Chairman of the Board of Intellego.
The board is working hard to protect the interests of all shareholders in a well-functioning company and a liquid share.
For the full decision, please refer to the Nasdaq website, www.nasdaq.com/market-regulation/nordic/stockholm/disciplinary/decisions-sanctions.
On MarketScreener I found further information on how to get rid of the worthless parts:
Intellego's share trades at 1 krone in the gray market - EFN
Published on 10.03.2026 at 14:10
After the technology company Intellego was delisted from First North, the opportunity arose to buy and sell shares outside the stock exchange in the so-called gray market.
According to information from EFN, trading will take place on Tuesday at a price of 1 krone per share, with the major bank SEB acting as broker. The purpose of the trade is reportedly to allow short sellers to exit their positions.
Intellego's shares were formally delisted on March 4. Trading in the stock had been suspended since November 18 of last year. The last price paid before the trading halt in November was 46.55 crowns per share.


So now its sure the stock is not coming back to the market. This is the first time for me this happend what can whe do with the shares i have ?
$INT Here is an analysis from Montega. Too bad about the good story, but I expect a total loss:
Rating from Montega AG on Intellego Technologies AB
Company: Intellego Technologies AB
ISIN: SE0016075063
Reason for the study: Update
Recommendation: n.a.
since: 09.02.2026
Target price: n.a.
Last rating change: -
Analyst: Ingo Schmidt, CIIA
KPMG report confirms worst fears
After Intellego Technologies as well as Nasdaq First North had the
the auditing company KPMG with a comprehensive special audit, the
the results of the forensic investigation were presented on January 30, 2026.
investigation were presented. While we had already pointed out irregularities
reporting irregularities at an early stage, the extent of the manipulations now
extent of the manipulation by former CEO Claes Lindahl that has now been revealed is
is shocking and puts the company to an enormous test.
Early warning signals confirmed: In our research update of
08.10. we had already suspended the rating for Intellego Technologies AB due to the
due to insufficient transparency. Our fears regarding the discrepancy
discrepancy between operating performance reports and the actual cash flow situation
cash flow situation have unfortunately been confirmed by recent events.
Systematic fraud by Claes Lindahl: The details published on January 30th
details published on January 30 show a degree of manipulation that goes far beyond
far beyond isolated errors. KPMG concludes that over 99% of the
of the sales reported for 2025 were systematically faked by Claes Lindahl
to deceive investors and the Board. According to the KPMG report
Lindahl systematically created two different sets of documents for the same orders/declarations of intent.
two different sets of documents. While one version, according to the KPMG report
real, often non-binding negotiations with potential customers, a second
potential customers, a second, manipulated version contained firm
acceptance commitments and fictitious payment and delivery terms. The latter
served as the basis for booking millions in sales that never actually existed.
never existed. In doing so, he apparently deceived all other
intellego employees and management colleagues as well as institutions such as the
the Swedish Export Credit Agency (SEK) and EKN by submitting manipulated
manipulated documents, which ultimately led to criminal charges of serious fraud.
fraud.
Executive Board fights for stock market listing - AGM at the end of February: The current Executive Board
is, by its own admission, endeavoring to come to terms with the events and is striving to
to maintain the company's stock market listing. We consider
this goal in view of the seriousness of the allegations and the necessary
forensic investigation of the financial statements. A
will be the Extraordinary General Meeting convened for February 23.
Extraordinary General Meeting convened for February 23. At this meeting, the management must
shareholders the extent to which a reliable database can be restored and what strategic
can be restored and what strategic options remain.
The most important consolidated holding Dario (UK), which was not part of the
which was not part of the investigations, could play a role.
Conclusion: The Intellego case remains a cautionary example of the importance of
of sound corporate governance and transparency. Our early warning has been
nevertheless surprised by the extent of the alleged criminal acts.
criminal acts. As long as the financial situation is not fully clarified
and audited financial statements are available, we are not in a position to value the share.
the share.
+++ This announcement does not constitute investment advice or an invitation to conclude
certain stock exchange transactions. Please read our RISK NOTICE /
DISCLAIMER at http://www.montega.de +++
About Montega:
Montega AG is an innovative investment banking boutique with a clear focus on medium-sized
focus on medium-sized companies and acts as a platform provider for the exchange
between listed companies and institutional investors.
Montega produces high-quality equity research, organizes a wide range of capital
capital market events in Germany and abroad and offers comprehensive support with
support with equity and debt financing. The mission:
To bring issuers and investors together and ensure transparency in the
stock market environment. In doing so, Montega concentrates on those market
market participants whose language the SME experts speak best
small and mid caps on the one hand and asset managers on the other,
family offices and investment boutiques with an investment focus in the small
on the other hand.
You can download the complete analysis here:
https://eqs-cockpit.com/c/fncls.ssp?u=44a18ff182b54552a8d4d28e458a6a0d
With $INT things are getting wilder and wilder.
There seems to be a system behind it and other companies are also affected:
What's more, the dismissed board member has now applied for a new board with one of the investors. What a soap opera by now. I don't think anyone would be surprised if more similar news were uncovered soon. Wirecard sends its regards.
Intellego Technologies AB (publ) (“Intellego” or the “Company”; $INT) announces that the product QIKcap, owned by its partner company HAI Solutions (HAIS), has today received approval from the U.S. Food and Drug Administration (FDA). The approval means that QIKcap may now be marketed and used within the U.S. healthcare system.
QIKcap is based on HAI Solutions’ patented technology, in which Intellego’s photochromic indicator technology constitutes an integrated and essential part of the now approved product.
Intellego holds an ownership interest of approximately 10.5 percent in HAIS and, in addition, has exclusive rights to sell QIKcap in the Chinese market. Intellego is also entitled to license revenues from global sales of the product.
“The FDA approval of QIKcap is an important milestone for HAI Solutions and enables future sales opportunities for Intellego in the Chinese market, as well as potential license revenues linked to global sales of QIKcap,” says Jacob Laurin, acting CEO of Intellego Technologies.
QIKcap is a single-use cap for intravenous access points, primarily catheters. The product combines a photochromic dosimeter and an optical lens to verify UVC exposure, with the aim of reducing the risk of intravenous contamination and bloodstream infections.
Link to HAI Solutions news: News — HAI Solutions
Contact
Jacob Laurin, acting CEO and Board Member, Intellego Technologies AB

First of all, I would like to thank everyone who took the time to read through Part 1 and also the many positive reactions.
So, as promised, here is Part 2! Of course, it's already getting a bit more detailed. First of all, the conditions under which this project is running, as not everyone will have read all the previous posts. Those who already know can skip this section.
There are many people who have already raised this amount and many more. My challenge is that I want to achieve the whole thing in 10 years and without making any major deposits. This requires a net return of around 45% p.a. An almost unbelievable return, which would mean a significant outperformance of the market and a considerably higher risk. From this you can conclude that the saying: a burnt child shuns fire does not really apply to me in terms of risk.
Since some people are also interested in the mindset with which you approach such a project, I have to say that my own story described in Part 1 also helps me. If you have lived with debts in the millions, €3,000 is a fly in the ointment. I have no pressure to make this project a success. If I end up with 65, 75 or 80 TE, that's fine too. Even a total loss of the stake, which won't happen now unless there is a total loss of value due to war, etc., won't kill me. Total losses of individual trades are just as much a part of it as 100% and more.
Nevertheless, I am very consistent in my management with regard to maximizing returns, which often leads to quick sales and I don't give the value enough time to develop. In addition, my approach is very different from some other very successful investors here, such as @Tenbagger2024 who invests a lot of time in finding great companies for himself and the community, analyzing them (thank you very much for that), but then often waits for his analysis to be confirmed and the value then simply runs away from him too quickly, or @Epi the most analytical person I know, who checks everything three times, does backtests and then does great things like 3xGTAA as a wiki. @Liebesspieler who can analyze all the key figures and knows exactly what they mean and how to assign them. @EpsEra who puts a lot of work into very elaborate analyses to perfectly analyze entire areas with all the companies that are active there. And also @TomTurboInvest the chart technology fan. Many thanks to you and everyone else I have not mentioned by name for all the work you put in to bring added value to the community. Special thanks also go to those who have dared to write a post or an analysis for the first time in recent weeks and months. I now have over 2,600 members following me here, but very few of them dare to actively contribute something themselves. I can only say again and again, have the courage!
What do I do differently? I react faster, I often act intuitively. I don't analyze every last key figure. When I find an interesting company that I believe can achieve my high requirements of at least 5% price performance per month, I go for it. I don't wait for any confirmations, whether technical or numerical. As a result, I often pick up percentages that others leave behind. This often works, as was recently the case with $ONDS (-0,76 %) ( first entry at 3.45$) or also at $GPCR but can of course also go wrong, as with $INT . That's part and parcel of betting primarily on small caps. For me, only the odds count. I don't have the ambition to find tenbaggers and hold the shares for so long. I prefer to take 200% or, as with $IREN (-1,65 %) times 450%. I reinvest the money in other stocks and get back in when the time is right.
If I am wrong and the trend is going in the wrong direction right from the start, the stocks are quickly sold again. Sometimes too early, of course, and the boom comes later.
So what must the development be like and what has been achieved so far?
Start 01.04.2023 3.000€
Calculated target:
31.03.2024 = € 4,350 Real status € 5,200 Performance year 1 approx. 73%
Since GQ does not import historical data except for TR, you have to believe it or not.
31.12.2024 = € 5,355 Real value € 9,200
Best months in 2024: January, October and February
Worst months in 2024: December, July and April
Overall, I had a ratio of 7 months with a positive result and 5 with a negative result. This is another good example of how risk management works, as the positive months were naturally much more positive than the negative ones. So, as the old saying goes, the trick is to let profits run and hedge, and limit losses.
Calculated target 31.12.2025= 8435,--€
Target multibagger 31.12.2025 = € 13,340
You can see the result in Deep Dive Part 3! When the year is really over. Since this was the first year where I was at GQ and tracked all depots, there will also be screenshots and proven figures.
So that's it for part 2! Part 3 will follow at the end of the year with the conclusion of 2025! Wishing everyone a happy 4th Advent.
Feel free to ask questions in between and I look forward to every reaction and comment
$INT The situation surrounding Intellego Technologies has worsened massively since the Nasdaq deadline expired last Friday. Contrary to the hope that the KPMG report would quickly clarify the situation, new, serious negative factors have emerged in recent days.
On December 17, the company announced that the major investor Heights Capital Management had filed official claims against Intellego. These claims are related to the capital increase on October 27, 2025, in which Heights Capital had subscribed for shares. As Intellego is still waiting for the exact specification of the amount of damages and the justification, it remains unclear whether it is a recovery of capital or compensation. However, this signals that institutional investors are now also taking legal action, which massively increases the financial pressure on the company.
In addition, it was announced on December 15 that proceedings have now also been initiated against board member Johan Möllerström on suspicion of serious fraud. This is a significant escalation as, following the arrest of former CEO Claes Lindahl in November, another key member of the company's management is now under criminal suspicion.
Trading in the share on Nasdaq First North remains completely suspended. The stock exchange is still intensively reviewing the company's statement submitted on December 12. A decision on the intended delisting or a possible resumption of trading is still pending. Market participants are particularly critical of the fact that the results of the forensic investigation by KPMG, which Intellego had firmly promised to publish, have still not been made available to the public. The lack of transparency with regard to these audit results further fuels the existing doubts about the integrity of the accounting.
$INT The deadline for submitting the statement to Nasdaq expired on Friday, December 12. Intellego submitted the statement on time, but did not make it public. not published publicly published, which severely restricts transparency on the market. The key findings of KPMG's forensic report are therefore still unknown.
Nasdaq Stockholm is now reviewing the extensive documentation. This review is expected to take days to weeks and will decide on the impending delisting. At the same time, the company is still legally defending itself against the asset freeze of SEK 230 million, against which an appeal was lodged on December 10.
The next critical news will be the official reaction of Nasdaq to the filed statement. Until this decision is made, trading in the shares will remain suspended.

$INT - Intellego Technologies AB has received a response to its request for an extension of time to respond to Nasdaq's notice of deficiency.
Nasdaq has granted an extension of one week granted.
The new deadline for submitting the statement is December 12, 2025.
Source :https://intellego-technologies.com/mfn_news/intellego-granted-additional-time-to-respond-to-nasdaq/